Pacing for neurally mediated syncope: is placebo powerless?

Europace. 2007 Jan;9(1):31-3. doi: 10.1093/europace/eul169.

Abstract

Background: After two recent controlled trials failed to prove superiority of cardiac pacing over placebo in patients affected by neurally mediated syncope, a widely accepted opinion is that cardiac pacing therapy is not very effective and that a strong placebo effect exists.

Aim: To measure the effect of placebo pacing therapy.

Method and results: We compared the recurrence rate of syncope during placebo vs. no treatment in controlled trials of drug or pacing therapy. Syncope recurred in 38% of 252 patients randomized to placebo pooled from five trials vs. 34% of 881 patients randomized to no treatment pooled from eight trials. The corresponding recurrence rate with active cardiac pacing was 15% in 203 patients from six trials.

Conclusions: Placebo is not an effective therapy for neurally mediated syncope. Different selection criteria in patients who are candidates for cardiac pacing-for example, presence, absence, or severity of the cardioinhibitory reflex may separate positive from negative trials.

MeSH terms

  • Follow-Up Studies
  • Humans
  • Pacemaker, Artificial / psychology*
  • Placebo Effect
  • Placebos
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Syncope / psychology*
  • Syncope / therapy*
  • Treatment Outcome

Substances

  • Placebos